Bridgeway Capital Management’s Xtant Medical Holdings XTNT Stock Holding History

Bridgeway Capital Management’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$91.6K	Hold	164,100	–	–	﹤0.01%	1129
2025 Q4	$129K	Hold	164,100	–	–	﹤0.01%	1096
2025 Q3	$106K	Hold	164,100	–	–	﹤0.01%	1102
2025 Q2	$121K	Sell	164,100 -25,000	-13%	-$14.2K	﹤0.01%	1043
2025 Q1	$88.9K	Sell	189,100 -99,900	-35%	-$52.6K	﹤0.01%	1059
2024 Q4	$128K	Sell	289,000 -4,500	-2%	-$2.18K	﹤0.01%	1081
2024 Q3	$198K	Hold	293,500	–	–	﹤0.01%	1070
2024 Q2	$185K	Sell	293,500 -75,000	-20%	-$59.8K	﹤0.01%	1069
2024 Q1	$431K	Hold	368,500	–	–	0.01%	959
2023 Q4	$416K	Buy	368,500 +200,000	+119%	+$235K	0.01%	985
2023 Q3	$185K	Buy	168,500 +54,000	+47%	+$57.9K	﹤0.01%	1121
2023 Q2	$106K	Hold	114,500	–	–	﹤0.01%	1248
2023 Q1	$73K	Hold	114,500	–	–	﹤0.01%	1278
2022 Q4	$75.6K	Hold	114,500	–	–	﹤0.01%	1255
2022 Q3	$82K	Sell	114,500 -232,500	-67%	-$127K	﹤0.01%	1306
2022 Q2	$180K	Hold	347,000	–	–	﹤0.01%	1112
2022 Q1	$236K	Sell	347,000 -25,000	-7%	-$16.4K	﹤0.01%	1140
2021 Q4	$208K	Sell	372,000 -123,900	-25%	-$117K	﹤0.01%	1158
2021 Q3	$550K	Buy	495,900 +204,998	+70%	+$267K	0.01%	1005
2021 Q2	$474K	Sell	290,902 -81,398	-22%	-$145K	0.01%	1079
2021 Q1	$879K	Buy	372,300 +222,300	+148%	+$475K	0.02%	907
2020 Q4	$179K	Buy	150,000 +25,000	+20%	+$32.2K	﹤0.01%	1223
2020 Q3	$103K	Sell	125,000 -46,916	-27%	-$45.9K	﹤0.01%	1255
2020 Q2	$155K	Buy	171,916 +121,916	+244%	+$112K	﹤0.01%	1184
2020 Q1	$34K	Hold	50,000	–	–	﹤0.01%	1242
2019 Q4	$80K	Hold	50,000	–	–	﹤0.01%	1260
2019 Q3	$142K	Hold	50,000	–	–	﹤0.01%	1218
2019 Q2	$150K	Hold	50,000	–	–	﹤0.01%	1217
2019 Q1	$153K	Hold	50,000	–	–	﹤0.01%	1251
2018 Q4	$81K	Hold	50,000	–	–	﹤0.01%	1318
2018 Q3	$193K	Hold	50,000	–	–	﹤0.01%	1326
2018 Q2	$278K	Buy	+50,000	New	+$334K	﹤0.01%	1264
2013 Q3	–	Sell	-213	Closed	-$12K	–	1498
2013 Q2	$12K	Buy	+213	New	+$17.6K	﹤0.01%	1395

Other funds holding XTNT

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bridgeway Capital Management's XTNT Position: Q1 2026 in Review

Bridgeway Capital Management held its Xtant Medical Holdings (XTNT) position steady in Q1 2026 at 164,100 shares worth $91.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

Bridgeway Capital Management first reported a position in XTNT in Q2 2013 and has held it in 33 quarters since. The position peaked at $879K in Q1 2021. 34 funds tracked by Wall St. Rank hold XTNT as of Q1 2026.

Bridgeway Capital Management held 164,100 shares of Xtant Medical Holdings worth $91.6K as of Q1 2026.
Bridgeway Capital Management left its Xtant Medical Holdings share count unchanged in Q1 2026.
Xtant Medical Holdings made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1129 holding.
Bridgeway Capital Management first reported a position in Xtant Medical Holdings in Q2 2013 and has held it in 33 quarters since.
Bridgeway Capital Management's Xtant Medical Holdings position peaked at $879K in Q1 2021.
34 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.